Programmed Cell Death (PD) Inhibitors Dominate Head and Neck Cancer Therapeutics Market with a share of 42.1% in 2024

By -

A new report from Industry Experts Inc, on "Head and Neck Cancer Therapeutics," is introduced. According to this global market research report, the global market for Head and Neck Cancer Therapeutics is estimated at US$1.7 billion in 2024 and is anticipated to post a CAGR of 9.4% during the 2024-2030 analysis period and stand at a projected US$3 billion by 2030.

The head and neck cancer market is primarily driven by increased research and development, which leads to the approval of new drugs, particularly for immunotherapy, targeted therapy, and chemotherapy. Healthcare providers are developing effective treatment options for several types of head and neck cancers, as evidenced by FDA approvals for drugs like Cetuximab and Docetaxel. Market growth is also driven by the rising incidence of HPV infections and increased consumption of alcohol and tobacco, which contribute to the prevalence of head and neck cancers.

Programmed Cell Death (PD) Inhibitors dominate the head and neck cancer therapeutics market with an estimated share of 42.1% in 2024 and is projected to be the fastest-growing therapeutic class, with a CAGR of 10.5% during the analysis period 2024-2030. These inhibitors have shown promising results in improving survival rates and extending progression-free survival, especially in patients with advanced or recurrent cancer.


The market for head and neck cancer therapeutics analyzed in this report on a global basis covering all major regions including North America (The United States, Canada, and Mexico), Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World.

The study analyzes the global market for head and neck cancer therapeutics analyzed with respect to Drug Class – Programmed Cell Death (PD) Inhibitors, Microtubule Inhibitors and Epidermal Growth Factor Receptor (EGFR) Inhibitors; Treatment Type – Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy and Surgery; Route of Administration – Injectable and Oral; and End-User – Hospitals, Specialty Clinics and Ambulatory Surgical Centers (ASCs).

About Industry Experts, Inc
Industry Experts, Inc., ranks among the leading market research providers globally. The company's off-the-shelf and customized business intelligence reports offer strategic insights and valuable guidance to enable various stakeholders, such as corporate strategists, analysts, researchers and startups, among others, in obtaining valuable, crisp and unbiased current and future market data. For more information, contact us on +1-320-497-3787 or visit https://industry-experts.com/

Comments

Post a Comment

Popular posts from this blog

Demand for Europium to Reach US$373.3 million by 2030 Fostered by Phosphors and Consumer Electronic Applications

By -
Image
Industry Experts, Inc., has released its latest report on Europium Market , which projects the demand for the same to reach US$373.3 million by 2030 from an estimated US$267.1 million in 2024 at a CAGR of 5.7% between the two years. The demand for Europium in the global market is primarily being driven by a number of factors that include increasing demand of phosphors in various applications for making high-quality displays that offer higher cooling, energy efficiency and brightness in products, such as OLEDs & LCDs, which are used in televisions, smart phones, wearables  and other electrical & electronic equipment. Technological advancements have enhanced the methods of extracting, purifying and separating europium from other ores, thereby positively impacting its availability to manufacturers. Heavy investments in R&D for improving performance and overcoming supply challenges of this metal have determined the global market in yielding innovative solutio...
Read more

Oil & Gas Fuels Demand for Duplex Stainless Steel and Global Market to Reach $6 billion by 2030

By -
Image
Industry Experts, Inc., has released its latest report, on Duplex Stainless Steel market, which projects the demand for the same to reach US$6 billion by 2030 from an estimated US$4.4 billion in 2024 at a CAGR of 5.4% between the two years. Some of the factors instrumental in driving demand for Duplex Stainless Steel include its widespread use in the oil & gas industry in the form of pipes & tubes. Comprising an almost equal proportion of austenitic and ferritic steels makes this variety of stainless steel very strong and highly resistant to corrosion, owing to which its application across various important end-use sectors has been growing rapidly.  The construction & infrastructure industry is another major consumer of Duplex Stainless Steels, as they are ideal for making bridges and other infrastructure projects. Apart from this, the chemical processing industry, subject to extreme operating environments, also makes extensive use of Duplex Stainless Ste...
Read more

Copper Demand to Reach US$368.8 B by 2030 Propelled by the Wide Range of Applications of the Metal Across Sectors

By -
Image
Industry Experts, Inc., has released its latest report, on Copper , which projects the demand for Copper to reach US$368.8 billion by 2030 from an estimated US$269 billion in 2024 at a CAGR of 5.4% between the two years. The use of copper and its alloys is quite extensive, contributing significantly to economic development. Major end-user sectors of this vital element include transportation, construction, consumer products, electrical & electronics and industrial machinery. The global demand for copper has been maintaining a steady growth, as statistics reveal a 300% growth in the use of refined copper over the last five decades across the industries mentioned above, reaching about 26.5 million tons in 2023. Other than being used in its primary form, copper is also among the most recycled materials, owing to which the market for secondary copper has been posting considerable growth. With an estimated share of about 41% in 2024, Asia-Pacific is the largest global marke...
Read more